haloperidol has been researched along with idazoxan in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (23.08) | 18.7374 |
| 1990's | 6 (23.08) | 18.2507 |
| 2000's | 8 (30.77) | 29.6817 |
| 2010's | 6 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Carmody, LC; Dandapani, S; Donckele, E; Feng, Y; Fernandez, C; Germain, AR; Gupta, PB; Lander, ES; Morgan, B; Munoz, B; Nag, PP; Palmer, M; Perez, JR; Schreiber, SL; Verplank, L | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Lookingland, KJ; Moore, KE; Tian, Y | 1 |
| Boulat, O; Maitre, L; Waldmeier, P | 1 |
| Hornykiewicz, O; Kobinger, W; Pichler, L; Pifl, C | 2 |
| Cichini, G; Kraupp, O; Singer, EA; Valenta, B | 1 |
| Bunney, BS; Chiodo, LA | 1 |
| Engel, JA; Goldstein, M; Johannessen, K; Liljequist, S | 1 |
| Clark, D; Eriksson, E; Svensson, K | 1 |
| Kulkarni, SK; Sharma, A | 1 |
| Novotney, S; Yamamoto, BK | 1 |
| Chariot, J; Fu-Cheng, X; Rozé, C; Souli, A | 1 |
| McAllister, KH; Rey, B | 1 |
| Chariot, J; Presset, O; Rozé, C; Souli, A; Tsocas, A | 1 |
| Devoto, P; Flore, G; Gessa, GL; Pani, L | 1 |
| Garavaglia, C; Invernizzi, RW; Samanin, R | 1 |
| Grottick, AJ; Herberg, LJ; Montgomery, AM | 1 |
| Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Lee, J | 1 |
| Svensson, TH; Wadenberg, ML; Wiker, C | 1 |
| Ball, GF; Castelino, CB; Cornil, CA | 1 |
| Artigas, F; Bortolozzi, A; Masana, M | 1 |
| Chau, DT; Dawson, R; Green, AI; Khokhar, JY | 1 |
26 other study(ies) available for haloperidol and idazoxan
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Topics: Amides; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Neoplastic Stem Cells; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Contribution of noradrenergic neurons to 3,4-dihydroxyphenylacetic acid concentrations in the regions of the rat brain containing incertohypothalamic dopaminergic neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Antagonists; Animals; Apomorphine; Brain Chemistry; Dioxanes; Dopamine; Haloperidol; Hydrolysis; Hypothalamus; Idazoxan; Injections, Intravenous; Male; Methoxyhydroxyphenylglycol; Neurons; Norepinephrine; Rats | 1991 |
3,4-Dihydroxyphenylacetic acid (DOPAC) as an index of noradrenaline turnover: effects of Hydergine and vincamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Bis(4-Methyl-1-Homopiperazinylthiocarbonyl)disulfide; Cerebellum; Dihydroergotoxine; Dioxanes; Dopamine; Dopamine beta-Hydroxylase; Drug Interactions; Female; Haloperidol; Hippocampus; Idazoxan; Locus Coeruleus; Norepinephrine; Prazosin; Rats; Vincamine | 1990 |
The dopamine autoreceptor agonist, B-HT 920, preferentially reduces brain dopamine release in vivo: biochemical indices of brain dopamine, noradrenaline and serotonin in ventriculocisternal perfusates in the cat.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic alpha-Agonists; Animals; Azepines; Brain; Cats; Cerebral Ventricles; Cisterna Magna; Dioxanes; Dopamine; Dopamine Agents; Female; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Idazoxan; Male; Norepinephrine; Serotonin | 1988 |
Effects of urapidil on catecholamine turnover and release in the central nervous system of the rat.
Topics: Animals; Blood Pressure; Brain Chemistry; Catecholamines; Chromatography, High Pressure Liquid; Dioxanes; Dopamine; Electric Stimulation; Haloperidol; Idazoxan; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Piperazines; Prazosin; Rats; Rats, Inbred Strains | 1989 |
Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons.
Topics: Anesthetics; Animals; Antipsychotic Agents; Biomechanical Phenomena; Chloral Hydrate; Clozapine; Dibenzazepines; Dioxanes; Dopamine; Drug Combinations; Haloperidol; Idazoxan; Male; Mesencephalon; Neurons; Prazosin; Rats; Rats, Inbred Strains; Trihexyphenidyl | 1985 |
The dopamine autoreceptor agonist B-HT 920 inhibits in vivo dopamine release into the cerebroventricular system of cats.
Topics: Adrenergic alpha-Agonists; Anesthesia; Animals; Azepines; Cats; Cerebral Ventricles; Dioxanes; Dopamine; Female; Haloperidol; Idazoxan; Male; Receptors, Dopamine | 1987 |
Activation of alpha 2-adrenoreceptors enhances haloperidol-induced suppression of operant behavior.
Topics: Animals; Behavior, Animal; Brain Chemistry; Clonidine; Conditioning, Operant; Dihydroxyphenylalanine; Dioxanes; Drug Interactions; Haloperidol; Idazoxan; Male; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha | 1986 |
The putative dopamine autoreceptor agonist B-HT 920 decreases nigral dopamine cell firing rate and prolactin release in rat.
Topics: Action Potentials; Animals; Azepines; Dioxanes; Dopamine; Haloperidol; Idazoxan; Iontophoresis; Male; Neurons; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine; Substantia Nigra; Trifluoperazine | 1985 |
On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Azepines; Benzazepines; Desipramine; Dioxanes; Dopamine; Female; Haloperidol; Idazoxan; Male; Muscle Contraction; Prazosin; Rats; Receptors, Adrenergic; Receptors, Dopamine; Reserpine; Sulpiride; Yohimbine | 1994 |
Regulation of extracellular dopamine by the norepinephrine transporter.
Topics: Adrenergic alpha-Antagonists; Animals; Carrier Proteins; Caudate Nucleus; Dopamine; Dopamine Antagonists; Extracellular Space; Haloperidol; Idazoxan; Indomethacin; Male; Microdialysis; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Symporters | 1998 |
Antisecretory effect of peptide YY through neural receptors in the rat jejunum in vitro.
Topics: Animals; Atropine; Haloperidol; Hexamethonium; Idazoxan; In Vitro Techniques; Jejunum; Male; Peptide YY; Pyrimidines; Rats; Rats, Wistar; Tetrodotoxin | 1999 |
Clozapine reversal of the deficits in coordinated movement induced by D2 receptor blockade does not depend upon antagonism of alpha2 adrenoceptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Ataxia; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Haloperidol; Idazoxan; Loxapine; Male; Muscarinic Antagonists; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Scopolamine; Yohimbine | 1999 |
Neural mechanism of the antisecretory effect of peptide YY in the rat colon in vivo.
Topics: Adrenergic alpha-Antagonists; Animals; Body Water; Colon; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Hexamethonium; Idazoxan; Intestinal Mucosa; Jejunum; Male; Nicotinic Antagonists; Peptide YY; Rats; Rats, Wistar; Sodium Channel Blockers; Tetrodotoxin; Vasoactive Intestinal Peptide | 2000 |
Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
Topics: 4-Butyrolactone; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cerebellum; Clonidine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Extracellular Space; Haloperidol; Idazoxan; Male; Microdialysis; Motor Cortex; Neurons; Norepinephrine; Prefrontal Cortex; Quinpirole; Rats; Rats, Sprague-Dawley; Solvents | 2001 |
The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
Topics: Adrenergic alpha-2 Receptor Antagonists; Catalepsy; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Idazoxan; Neurons; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin | 2003 |
Alpha2-adrenoceptor antagonism is neither sufficient nor necessary for the distinctive action of atypical neuroleptics on intracranial self-stimulation in the rat.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Clonidine; Haloperidol; Idazoxan; Male; Motivation; Olanzapine; Pirenzepine; Rats; Receptors, Adrenergic, alpha-2; Self Stimulation | 2003 |
A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease.
Topics: Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Amantadine; Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Dizocilpine Maleate; Dopamine Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Haloperidol; Idazoxan; Levodopa; Male; Motor Activity; Parkinson Disease; Rats; Rats, Sprague-Dawley; Reserpine | 2005 |
Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Catalepsy; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Haloperidol; Idazoxan; Male; Microdialysis; Motor Activity; Nucleus Accumbens; Olanzapine; Prefrontal Cortex; Rats; Rats, Wistar | 2007 |
Dopamine binds to alpha(2)-adrenergic receptors in the song control system of zebra finches (Taeniopygia guttata).
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Clozapine; Dopamine; Finches; Haloperidol; Homeostasis; Idazoxan; Male; Raclopride; Receptors, Adrenergic, alpha-2; Vocalization, Animal | 2008 |
Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
Topics: Adrenergic Agents; Animals; Antipsychotic Agents; Cognition; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Electric Stimulation; Haloperidol; Idazoxan; Male; Microdialysis; Molecular Targeted Therapy; Morpholines; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Nucleus Accumbens; Prefrontal Cortex; Rats; Rats, Wistar; Reboxetine; Schizophrenia; Synaptic Transmission; Ventral Tegmental Area | 2011 |
Clozapine reconstructed: Haloperidol's ability to reduce alcohol intake in the Syrian golden hamster can be enhanced through noradrenergic modulation by desipramine and idazoxan.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Adult; Alcohol Drinking; Animals; Clozapine; Desipramine; Dose-Response Relationship, Drug; Drug Synergism; Eating; Female; Haloperidol; Humans; Idazoxan; Male; Mesocricetus; Receptors, Dopamine D2 | 2015 |